[Federal Register Volume 69, Number 153 (Tuesday, August 10, 2004)]
[Notices]
[Page 48523]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-18174]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 5, 2004, and published in the Federal 
Register on March 15, 2004, (69 FR 12178), Johnson Matthey, Inc., 
Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New 
Jersey 08066, made application by letter to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
Methamphetamine (1105), and Hydromorphone (9150), the basic classes of 
controlled substances listed in Schedule II. The firm had inadvertently 
dropped the two basic classes from its renewal application submitted on 
August 25, 2003, and published in the Federal Register on February 18, 
2004 (69 FR 7656).
    The company plans to manufacture the listed controlled substances 
in bulk to supply to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Johnson Matthey, Inc., to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Johnson Matthey, Inc., to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: July 28, 2004.
Joseph T. Rannazzisi,
Deputy Director, Office of Diversion Control, Drug Enforcement 
Administration.
[FR Doc. 04-18174 Filed 8-9-04; 8:45 am]
BILLING CODE 4410-09-M